How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values

Determination of a Tentative Epidemiological Cut-Off Value (ECOFF) for Dalbavancin and Enterococcus faecium

(2021) Robert E. Weber et al.   Antibiotics-Basel

Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values

(2020) O. Karatuna et al.   CLINICAL MICROBIOLOGY AND INFECTION

Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis

(2020) Qiwen Yang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Susceptibility Patterns and Wild-Type MIC Distributions of Anaerobic Bacteria at a German University Hospital: A Five-Year Retrospective Study (2015–2019)

(2020) Mohamed Tarek Badr et al.   Antibiotics-Basel

Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study

(2018) Nazir A. Ismail et al.   EBioMedicine

Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe

(2016) David M. Aanensen et al.   mBio

Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing

(2012) E. Zankari et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species

(2009) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions

(2009) M. Sjölund et al.   CLINICAL MICROBIOLOGY AND INFECTION

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

(2009) T. Schon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY